Exide vs Amara Raja: H1 FY26, EV capex talk

Battery stocks are being debated again because investors see the sector shifting from lead-acid to lithium-ion for EVs and energy storage. Reddit threads and market posts are placing Exide Industries and Amara Raja Energy and Mobility (ARE&M) side by side on financials, valuation and capex readiness. The discussion is not only about who sells more today, but also who is building lithium-ion capacity faster. Several posts also highlight that near-term quarterly moves can look noisy even when the longer-term plan is unchanged. Below is a clean summary of what was shared, using only the figures and claims circulating in the trending context.

Why Exide vs Amara Raja is trending now

The biggest driver in the discussion is the industry shift away from lead-acid dominance toward lithium-ion batteries. Posts point out that vehicles and inverters still use lead-acid widely, but EV adoption and grid-scale storage are pushing lithium-ion demand. As a result, both companies are being judged on how quickly they can scale cell manufacturing, not just finished batteries. Investors are also comparing near-term earnings stability with long-term capex ambition. Another reason for the debate is that both companies reported similar growth in H1 FY26 in the shared numbers. Despite similar margins in the H1 snapshot, Q2 commentary in the same threads shows different short-term outcomes. Valuation multiples and dividend yields are also part of the social chatter. The conversation often blends hard numbers with forward-looking expectations, so it helps to separate reported figures from opinions.

H1 FY26 headline numbers being shared

A frequently reposted table compares Exide and ARE&M for H1 FY26 on revenue, growth and profitability. Exide is described as larger in scale based on revenue. Both companies show the same revenue growth rate in the shared snapshot. EBITDA margin is also shown as identical, suggesting similar margin pressure in that period. Net profit numbers in the same H1 comparison are very close. EPS differs sharply, which the posts attribute to differences in share count rather than a dramatic gap in absolute profit. These figures are being used to argue that the core business is steady for both, at least in the half-year view. Here is the H1 FY26 comparison exactly as it appeared in the trending context.

Margins, PAT and the EPS mismatch

The most repeated takeaway from the H1 FY26 snapshot is that PAT is almost the same for the two companies. In that framing, the EPS gap is treated as a structure issue, not a profitability surprise. Several investors on social media use this to caution against comparing EPS without checking share count. The identical EBITDA margin figure (10.7% for both) is being interpreted as evidence of industry-wide margin constraints. At the same time, separate posts reference multi-year profitability comparisons where Amara Raja is portrayed as stronger on margins and growth over longer periods. Those longer-period posts include claims of higher operating profit margin for Amara Raja (14% vs 11% for Exide) and higher three-year compounded profit growth (12% vs 2%). Because these ratio sets come from different social sources, readers are being urged in threads to cross-check with official filings. The key point from the trending discussion is that the H1 snapshot looks close, while broader historical narratives differ depending on the dataset quoted.

Q2 FY26: GST timing cited for Exide, growth for ARE&M

The quarter-on-quarter debate is largely anchored around Q2 FY26 claims shared in Hindi-language posts. For ARE&M, Q2 FY26 revenue is cited at ₹3,467 crore, up 7% year-on-year, with profit at ₹276 crore, up 17%. For Exide, the same threads say Q2 FY26 revenue fell 2% and profit fell 25%. The most repeated explanation for Exide’s Q2 drop is a GST-related timing issue where distributors paused buying after a GST reduction. Social posts frame this as a temporary shock rather than a structural demand issue. For Exide, commenters also flag raw material exposure, especially lead price volatility, as a recurring earnings risk. For ARE&M, the Q2 numbers are used to argue that the company’s financial momentum looks better in the near term. Investors following the debate are therefore separating one-off timing impacts from underlying execution.

Balance sheet and cash flow points discussed online

Some posts label Exide as a “zero debt company” and also claim strong cash flow generation of more than ₹500 crore in H1. These points are being used to argue that Exide can fund large capex without stressing leverage. Other comparison posts share debt-to-equity ratios of 0.05 for Amara Raja versus 0.14 for Exide, suggesting both are low-leverage, with Amara Raja lower in that specific dataset. Liquidity ratios are also circulated, with a current ratio of 1.56 for Amara Raja versus 1.34 for Exide, and a quick ratio of 0.69 versus 0.49. Contingent liabilities are quoted as ₹179 crore for Amara Raja and ₹271 crore for Exide in the same dataset. Separately, interest coverage is quoted at 43.9x for Amara Raja and 15.5x for Exide for FY2023. Since these figures come from social summaries, commenters often treat them as directional indicators rather than definitive. The consistent theme, however, is that both companies are portrayed as financially stable enough to attempt lithium-ion expansion.

Lead-acid market share still matters in the debate

Even with EVs in focus, market share in lead-acid batteries is a recurring comparison point. One widely shared table pegs Exide’s lead-acid market share at 18% and Amara Raja’s at 25%. This is used to support the view that Amara Raja is strong in its core lead-acid franchise. Other social snippets describe Exide as having the highest domestic market presence and strength in the replacement segment, while Amara Raja is described as the second-largest player. This difference in framing shows how market-share talk varies across posts. The broader investor conclusion in these threads is that lead-acid cash flows can still finance new energy investments. At the same time, lead exposure is repeatedly mentioned as a risk factor, particularly for Exide, due to raw material volatility. The lead-acid angle therefore remains a key part of the risk-reward discussion.

Lithium-ion plans: 6 GWh ambition vs phased scaling

Most of the bullish or bearish arguments eventually come back to lithium-ion capex timelines. Posts claim Exide is investing ₹5,000 crore in EV future projects, with ₹3,947 crore already invested. Exide is also said to be building a 6 GWh lithium gigafactory, split evenly between NMC and LFP cells. The same discussion expects a trial run by the end of FY26, and frames it as potentially India’s first large-scale cell factory. For Amara Raja, posts state ₹1,200 crore has been invested in the new energy business, with a plan to invest ₹1,400-1,500 crore more in FY26. A 1 GWh NMC cell plant is cited as under work, and a longer-term target of 16 GWh capacity by 2030 is mentioned. Social media narratives therefore position Exide as earlier on near-term capacity scale, while positioning Amara Raja as aggressive on long-horizon expansion. Investors in the threads often say the important proof points will be commissioning milestones, yields and ramp-up stability.

Stock metrics: price, valuation and dividends in circulation

Social posts also compare current prices, market caps and valuation multiples to anchor sentiment. One snapshot says ARE&M closed at ₹952 (+0.70%) while Exide closed at ₹374.95 (+1.79%) on the referenced Friday. The same table puts market cap at ₹31,876 crore for Exide and ₹17,422 crore for ARE&M. Valuation is shown as P/E of about 32 for Exide and 21.6 for ARE&M in that dataset. Dividend yield is shown as 0.53% for Exide and 1.10% for ARE&M. The 52-week ranges shared are ₹472.50 to ₹328 for Exide and ₹1,360 to ₹805 for ARE&M. Posts also claim Exide delivered 100.97% return over five years, while Amara Raja has returned 17,291% since listing, a figure that circulates often in social comparisons. These metrics are used to argue that the market is already pricing Exide at a higher premium than ARE&M, while also acknowledging the different base and time frames.

What investors say they will track next

The next checkpoints highlighted in discussions are mainly operational and timeline-driven. For Exide, the trial run expectation by end-FY26 is treated as a key event for sentiment. For Amara Raja, the pace of execution toward its 1 GWh project and the credibility of the 16 GWh by 2030 target are central to the debate. On the earnings side, many are watching whether Exide’s GST timing disruption normalises and whether demand rebounds as expected. Lead price volatility remains a commonly cited risk that can move margins regardless of volume growth. Investors also compare whether efficiency upgrades translate into margin lift, a point mentioned in Exide-focused posts. On valuation, the recurring argument is that premium multiples need visible progress on lithium commissioning. In short, the social narrative is split into two timelines: near-term earnings volatility versus multi-year EV and energy storage optionality.